Kidney Function Decline and Apparent Treatment-Resistant Hypertension in the Elderly

PloS One
Jean KaboréBenedicte Stengel

Abstract

Cross-sectional studies show a strong association between chronic kidney disease and apparent treatment-resistant hypertension, but the longitudinal association of the rate of kidney function decline with the risk of resistant hypertension is unknown. The population-based Three-City included 8,695 participants older than 65 years, 4265 of them treated for hypertension. We estimated the odds ratios (OR) of new-onset apparent treatment-resistant hypertension, defined as blood pressure ≥ 140/90 mmHg despite use of 3 antihypertensive drug classes or ≥ 4 classes regardless of blood pressure, associated with the mean estimated glomerular filtration rate (eGFR) level and its rate of decline over 4 years, compared with both controlled hypertension and uncontrolled nonresistant hypertension with ≤ 2 drugs. GFR was estimated with three different equations. Baseline prevalence of apparent treatment-resistant hypertension and of controlled and uncontrolled nonresistant hypertension, were 6.5%, 62.3% and 31.2%, respectively. During follow-up, 162 participants developed apparent treatment-resistant hypertension. Mean eGFR decline with the MDRD equation was 1.5±2.9 mL/min/1.73 m² per year: 27.7% of the participants had an eGFR ≥3 and 10.1% ≥ ...Continue Reading

References

Apr 1, 1985·Journal of the American Geriatrics Society·R D LindemanN W Shock
Jul 31, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Marcello TonelliBryce A Kiberd
Dec 6, 2003·Hypertension·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Dec 7, 2005·Journal of Hypertension·Pauline BrindelUNKNOWN 3C Study Investigators
Jan 26, 2006·Journal of the American Society of Nephrology : JASN·Auke H BrantsmaRonald T Gansevoort
Aug 16, 2006·Annals of Internal Medicine·Andrew S LeveyUNKNOWN Chronic Kidney Disease Epidemiology Collaboration
Apr 2, 2008·Annals of Internal Medicine·Bryan KestenbaumDavid S Siscovick
Mar 3, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Andrew S LeveyJosef Coresh
May 28, 2009·Hypertension·Laura C PlantingaUNKNOWN Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team
Apr 16, 2011·Journal of the American Society of Nephrology : JASN·Marie BrietUNKNOWN Nephrotest Study Group
Jun 17, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Benedicte StengelCatherine Helmer
Mar 2, 2012·Circulation·Stacie L DaughertyP Michael Ho
Oct 3, 2012·Annals of Internal Medicine·Elke S SchaeffnerPeter Martus
May 24, 2013·Kidney International·Louise RoySylvie Perreault
Jul 12, 2013·Journal of Nephrology·Laetitia KoppeAoumeur Hadj-Aissa
Jul 23, 2013·Clinical Journal of the American Society of Nephrology : CJASN·Rikki M TannerPaul Muntner
Jan 31, 2014·Journal of the American Geriatrics Society·Guangyan CaiUNKNOWN Survey of Prevalence, Awareness, and Treatment Rates in Chronic Kidney Disease Patients with Hypertension in China Collabora
Feb 25, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Emmanuelle Vidal-PetiotMartin Flamant
Mar 20, 2014·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hong XuJuan Jesús Carrero
Apr 30, 2014·Revista Española De Cardiología·Teresa Gijón-CondeJosé R Banegas
May 9, 2014·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Francesca Viazzi, Roberto Pontremoli

❮ Previous
Next ❯

Citations

Aug 29, 2019·American Journal of Physiology. Renal Physiology·Emily E SchmittDanielle R Bruns

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

SAS

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Clinical Journal of the American Society of Nephrology : CJASN
Rikki M TannerPaul Muntner
European Journal of Epidemiology
Auni JuutilainenMika Kastarinen
Jornal brasileiro de nefrologia : ʹorgão oficial de Sociedades Brasileira e Latino-Americana de Nefrologia
Natália Maria da Silva FernandesMarcus Gomes Bastos
© 2021 Meta ULC. All rights reserved